As medical device technologies continue to evolve, active implanted medical devices have gained increasing popularity in the medical field. For example, one type of implanted medical device includes neurostimulator devices, which are battery-powered or battery-less devices that are designed to deliver electrical stimulation to a patient. Through proper electrical stimulation, the neurostimulator devices can provide pain relief for patients.
An implanted medical device, for example a neurostimulator, can be controlled using an electronic programming device such as a clinician programmer or a patient programmer. These programmers can be used by medical personnel or the patient to define the particular electrical stimulation therapy to be delivered to a target area of the patient's body or alter one or more parameters of the electrical stimulation therapy. When a medical device is implanted into a patient or when one or more parts of an existing implanted system are replaced, information about the implanted medical devices must be provided to the clinician programmer and other associated systems to prepare the medical device for configuration, programming, operation, and monitoring. Current methods for identifying the medical device to the clinician programmer and other associated systems are time consuming and prone to error.
Therefore, although electronic programming devices for controlling implanted medical devices have been generally adequate for their intended purposes, they have not been entirely satisfactory in every aspect.
One of the broader forms of the present disclosure involves a system for operating a medical device, the system comprises a medical programmer and a medical device associated with a machine-readable representation of data. The medical programmer includes a sensor configured to detect the machine-readable representation of data and a display configured to graphically display a digital image of the medical device associated with the machine-readable representation of data.
Another one of the broader forms of the present disclosure involves a method for operating a medical device. The method comprises interpreting a first machine-readable representation of data and identifying a first medical device associated with the first representation of data. The method also includes graphically representing the identified first medical device on a medical device programmer configured to program a function of the first medical device.
Another one of the broader forms of the present disclosure involves a programmer for operating an implanted medical device. The programmer comprises a sensor configured to detect a machine readable representation of data. The programmer also comprises a graphic display configured to display an image of a patient anatomy and an image of a medical device associated with the machine-readable representation of data. The image of the medical device on the display is movable relative to the image of the patient anatomy in response to a user input. The programmer also includes a transmitter operable to wirelessly communicate with the medical device.
Aspects of the present disclosure are best understood from the following detailed description when read with the accompanying figures. It is emphasized that, in accordance with the standard practice in the industry, various features are not drawn to scale. In fact, the dimensions of the various features may be arbitrarily increased or reduced for clarity of discussion. In the figures, elements having the same designation have the same or similar functions.
It is to be understood that the following disclosure provides many different embodiments, or examples, for implementing different features of the invention. Specific examples of components and arrangements are described below to simplify the present disclosure. These are, of course, merely examples and are not intended to be limiting. Various features may be arbitrarily drawn in different scales for simplicity and clarity.
Electronic programmers may be used to control the operation of active medical devices such as neurostimulators, cardiac pacemakers, defibrillators, monitors, cardiac assist devices, resynchronization therapy devices, drug pumps, hearing implants, cochlear implants, deep brain stimulators, artificial hearts, incontinence devices, bone growth stimulators, gastric pacemakers, prosthetic devices, and implanted sensor networks. These electronic programmers include clinician programmers and patient programmers, each of which may be a handheld device. A clinician programmer allows a medical user (e.g., a doctor or a nurse) to define a particular therapy to be delivered to a target area of the patient's body, while a patient programmer allows a patient to alter one or more parameters of the therapy.
Typically, before attaching an active medical device to either an internal or external location of a patient anatomy, the device is registered with an electronic programmer. This registration process can include providing to the programmer identification information about the device such as a part number, a serial number, or another identifying indicator. Manual entry of this identification information is time consuming and prone to error.
Neural tissue (not illustrated for the sake of simplicity) branches off from the spinal cord through spaces between the vertebrae. The neural tissue can be individually and selectively stimulated in accordance with various aspects of the present disclosure. For example, referring to
The electrodes 105 deliver current drawn from the current sources in the IPG device 102, therefore generating an electric discharge and field near the neural tissue. This stimulates the neural tissue to accomplish its intended functions. For example, the neural stimulation may alleviate pain in an embodiment. In other embodiments, a stimulator as described above may be placed in different locations throughout the body and may be programmed to address a variety of problems, including for example but without limitation; prevention or reduction of epileptic seizures, weight control or regulation of heart beats.
It is understood that the IPG device 102, the lead 104, and the electrodes 105 may be implanted completely inside the body 108, may be positioned completely outside the body or may have only one or more components implanted within the body while other components remain outside the body. When they are implanted inside the body, the implant location may be adjusted (e.g., anywhere along the spine 1000) to deliver the intended therapeutic effects of spinal cord electrical stimulation in a desired region of the spine. Furthermore, it is understood that an IPG type device with corresponding leads and electrodes may be positioned adjacent nerves in the limbs, head or other portions of the trunk of a patient
The electronic programmer 106 communicates with one or both of the medical devices 102, 104 via a wired or a wireless communication link. In one embodiment, signals are transmitted and received with the electronic programmer 106 at Radio Frequencies (RF).
In one embodiment, for example, the medical device 102 may be an implanted pulse generator (IPG) and the medical device 104 may be a stimulation lead. As illustrated in
The electronic programmer 106 may communicate via a wired or a wireless communication link with support equipment such as a computer 110 and a printer 112. In alternative embodiments, the electronic programmer may transmit or receive information in wired or wireless form from other electronic programmers, medical equipment, display devices, data storage devices, or other electronic equipment via direct or network links.
Referring now to
The IPG 120 also includes connector ports 124 sized and shaped to receive leads that are routed to anatomic locations for neurostimulation. In one embodiment, permanently or temporarily affixed to the IPG 120, a data tag 126 includes a machine-readable representation of data. The data tag 126 may include, for example, a linear barcode, a two-dimensional (2D) barcode, alphanumeric characters capable of being read by an optical character recognition (OCR) device, and/or a radio-frequency identification antenna and chip. The data included in the machine-readable representation of data may include IPG identification information such as a serial number, a part number, a manufacturing date, the device type, and a lot number. Additional data about the IPG may be included in the machine-readable representation of data or may be accessed from a related product database. Such additional information may include physical information about the IPG such as size and shape; functional information about the IPG such as the battery status or the charge density; relational information about the IPG such as which leads or implantation instruments are suitable for use with the IPG; calibration information; and safety information about the IPG such as warnings or recall information. The data tag 126 may be removable prior to implanting the IPG 120 in a patient or may be biocompatible for implantation with the IPG. The IPG 120 is enclosed in packaging 128 which includes a data tag 130 that includes a machine-readable representation of data. The data tag 130 may represent the same data as the data tag 126 or may represent different data. In this embodiment, both the packaging and the IPG include a data tag, but in alternative embodiments, a data tag may be omitted from either the packaging or the IPG.
Referring now to
Referring now to
The programmer 106 includes a housing surrounding a touch sensitive display 157 operable to receive commands from the user, and a scanning system 158 for detecting and scanning a machine-readable representation of data. As shown in greater detail in
The display 157 is operable to present information to the user of the programmer 106. The display 157 includes a graphical screen output, examples of which are shown in
The clinician programmer 106 includes memory 162, which can be internal to the processor 160 (e.g., memory 305), external to the processor 160 (e.g., memory 310), or a combination of both. The memory 162 stores sets of instructional information with stimulation control parameters that are available to be selected for delivery through the communication interface 166 to the IPG 102 for electrical stimulation therapy. Exemplary memory include a read-only memory (“ROM”), a random access memory (“RAM”), an electrically erasable programmable read-only memory (“EEPROM”), a flash memory, a hard disk, or another suitable magnetic, optical, physical, or electronic memory device. The processor 160 executes software that is capable of being stored in the RAM (e.g., during execution), the ROM (e.g., on a generally permanent basis), or another non-transitory computer readable medium such as another memory or a disc. The programmer 106 also includes input/output (“I/O”) systems that include routines for transferring information between components within the processor 160 and other components of the programmer or external to the programmer. As shown in
Software included in the implementation of the programmer 106 is stored in the memory 305 of the processor 160, RAM 310, ROM 315, or external to the programmer 106. The software includes, for example, firmware, one or more applications, program data, one or more program modules, and other executable instructions. The processor 160 is configured to retrieve from memory and execute, among other things, instructions related to the control processes and methods described below for the programmer 106. For example, the processor 160 is configured to execute instructions retrieved from the memory 162 for establishing a protocol to control the IPG 102. Some embodiments include software modules configured to provide instructions for accomplishing particular tasks handled by the programmer 106. For example, the programmer includes a programming software module configured to generate a treatment or stimulation program based on input received from a user of the programmer. Still further, the programmer may include a software module for detection of machine readable codes and graphic display of associated implantable devices.
Referring now to
At step 174, the programmer 106 references an internal or external data storage device to identify information associated with the recognized serial number. The information identified may include physical information about the IPG such as size and shape; functional information about the IPG such as current-density and charge density limits to be enforced for each attached lead; relational information about the IPG such as which leads or implantation instruments are suitable for use with the IPG; and safety information about the IPG such as warnings or recall information. This information may be used to display an image of the IPG 120 and to accurately perform calculations associated with the IPG. The information may also be used to configure other graphic screens that may be utilized with the identified IPG. Portions of the identified information may be displayed on the display 157, output to a printer 112 for printing a patient record, or transmitted to other networked computers or cloud servers for record keeping. The identified information may be stored in the programmer 106. In one embodiment, the identified information may be stored for later display rather than for immediate display.
At step 176, a determination is made as to whether additional medical devices will be used for the implantation procedure. In this embodiment, because the lead 140 will also be implanted with the IPG 120, the steps 172 and 174 are repeated wherein the data tag 154, in this case a 2D bar code, is scanned by the scanning system 158 to identify physical, functional, relational, and safety information about the lead 140.
At step 178, the scanned data is used to configure a user interface for the programmer 160. For example, images of the medical devices, IPG 120 and the lead 140, are graphically represented on the display 157. In one embodiment, only the identified medical devices will be displayed on the display 157. In alternative embodiments, the identified medical devices may be displayed with other medical devices, but the identified medical devices may be graphically emphasized to indicate to a viewer, which graphically displayed medical devices correspond to the scanned medical devices. For example, in one embodiment (see,
At step 180, images of the medical devices, IPG 120 and the lead 140, may be displayed on the display 157 together with an image of an anatomic location. For example, in one embodiment (see,
At step 182, the association between the actual medical devices 120, 140 may be recorded by using the programmer 106. For example, if the actual lead 140 is connected to the actual IPG 120, a graphic representation of the connection may be displayed on the display 157. Although the use of only one IPG lead has been described, it is understood that a plurality of leads, extensions, adaptors or other medical devices for use with an IPG may be scanned and displayed on the display 157 for connection to the IPG.
The information associated with the scanned barcode may also be accessed for use in internal calculations performed by the programmer 106, including the setting of stimulation limits to prevent damage to the neural tissue that is stimulated. The information may also be used by the programmer to update and print out patient records that include the scanned information. The programmer may also transmit the scanned information to a database of the clinic, the manufacturer, a government entity or other organization that may use the information for record-keeping. The scanned information may also be used to configure the medical device and/or the patient programmer to allow the patient to control the medical device, within limits. The scanned information may also configure the medical device for use with the other scanned medical devices to be used in a procedure on the patient. The scanned information may also be used to store or retrieve data associated with the identifying information, such as a patient record.
The use of a scanning system to enter identifying information about medical devices may decrease the time associated with entering device information into the programmer, as compared to manual entry of the same information. The use of a scanning system may also reduce the likelihood of entry errors associated with manual entry. For example, the scanning system may include error checking features that prompt a user to rescan the data tag or otherwise indicate to the user that the scanned medical device is not recognized.
Referring now to
Referring now to
As shown in
While only a single lead placement has been illustrated, it will be understood that as may graphical implant objects may be placed in the combination display area as needed to accurately represent the physical leads being positioned in the patient along with the connection to the appropriate pulse generator. It will be understood that the displayed connection to the IPG will represent the physical connections such that connections to the IPG may be limited for a given model indicating to the user that a different pulse generator model should be selected.
Although an IPG 120 is used here as an example, it is understood that the various aspects of the present disclosure apply to an external pulse generator (EPG) as well. An EPG is intended to be worn externally to the patient's body. The EPG connects to one end of one or more percutaneous, or skin-penetrating, leads. The other end of the percutaneous lead is implanted within the body and incorporates multiple electrode surfaces analogous in function and use to those of an implanted lead. Likewise, the aspects of this disclosure apply to an optional internal/external pulse generator (XPG) that may be either implanted in a patient anatomy or worn externally of the patient's body.
The foregoing has outlined features of several embodiments so that those skilled in the art may better understand the detailed description that follows. Those skilled in the art should appreciate that they may readily use the present disclosure as a basis for designing or modifying other processes and structures for carrying out the same purposes and/or achieving the same advantages of the embodiments introduced herein. Those skilled in the art should also realize that such equivalent constructions do not depart from the spirit and scope of the present disclosure, and that they may make various changes, substitutions and alterations herein without departing from the spirit and scope of the present disclosure.
Number | Name | Date | Kind |
---|---|---|---|
4432360 | Mumford et al. | Feb 1984 | A |
5286202 | De Gyarfas et al. | Feb 1994 | A |
5304206 | Baker, Jr. et al. | Apr 1994 | A |
5312446 | Holschbach et al. | May 1994 | A |
5370672 | Fowler et al. | Dec 1994 | A |
5383914 | O'Phelan | Jan 1995 | A |
5421830 | Epstein et al. | Jun 1995 | A |
5628776 | Paul et al. | May 1997 | A |
5713937 | Nappholz et al. | Feb 1998 | A |
5722999 | Snell | Mar 1998 | A |
5724996 | Piunti | Mar 1998 | A |
5819740 | Muhlenberg | Oct 1998 | A |
5879374 | Powers et al. | Mar 1999 | A |
5905500 | Kamen et al. | May 1999 | A |
5938690 | Law et al. | Aug 1999 | A |
6016447 | Juran et al. | Jan 2000 | A |
6016448 | Busacker et al. | Jan 2000 | A |
6052624 | Mann | Apr 2000 | A |
6083156 | Lisiecki | Jul 2000 | A |
6148233 | Owen et al. | Nov 2000 | A |
6154675 | Juran et al. | Nov 2000 | A |
6216036 | Jenkins et al. | Apr 2001 | B1 |
6246414 | Kawasaki | Jun 2001 | B1 |
6249705 | Snell | Jun 2001 | B1 |
6278890 | Chassaing et al. | Aug 2001 | B1 |
6307554 | Arai et al. | Oct 2001 | B1 |
6308102 | Sieracki et al. | Oct 2001 | B1 |
6345200 | Mouchawar et al. | Feb 2002 | B1 |
6386882 | Linberg | May 2002 | B1 |
6442432 | Lee | Aug 2002 | B2 |
6525727 | Junkins et al. | Feb 2003 | B1 |
6564104 | Nelson et al. | May 2003 | B2 |
6587104 | Hoppe | Jul 2003 | B1 |
6611267 | Migdal et al. | Aug 2003 | B2 |
6622048 | Mann et al. | Sep 2003 | B1 |
6669631 | Norris et al. | Dec 2003 | B2 |
6786405 | Wiedenhoefer | Sep 2004 | B2 |
6852080 | Bardy | Feb 2005 | B2 |
6882982 | McMenimen et al. | Apr 2005 | B2 |
6895280 | Meadows et al. | May 2005 | B2 |
6920360 | Lee et al. | Jul 2005 | B2 |
6931155 | Gioia | Aug 2005 | B1 |
6961448 | Nichols et al. | Nov 2005 | B2 |
6961617 | Snell | Nov 2005 | B1 |
7003349 | Andersson et al. | Feb 2006 | B1 |
7034823 | Dunnet | Apr 2006 | B2 |
7058453 | Nelson et al. | Jun 2006 | B2 |
7060030 | Von Arx et al. | Jun 2006 | B2 |
7065409 | Mazar | Jun 2006 | B2 |
7066910 | Bauhahn et al. | Jun 2006 | B2 |
7076303 | Linberg | Jul 2006 | B2 |
7087015 | Comrie et al. | Aug 2006 | B1 |
7092761 | Cappa et al. | Aug 2006 | B1 |
7107102 | Daignault et al. | Sep 2006 | B2 |
7142923 | North et al. | Nov 2006 | B2 |
7181286 | Sieracki et al. | Feb 2007 | B2 |
7181505 | Haller et al. | Feb 2007 | B2 |
7184837 | Goetz | Feb 2007 | B2 |
7239926 | Goetz | Jul 2007 | B2 |
7266412 | Stypulkowski | Sep 2007 | B2 |
7299085 | Bergelson et al. | Nov 2007 | B2 |
7359751 | Erickson et al. | Apr 2008 | B1 |
7373204 | Gelfand et al. | May 2008 | B2 |
7440806 | Whitehurst et al. | Oct 2008 | B1 |
7452336 | Thompson | Nov 2008 | B2 |
7463927 | Chaouat | Dec 2008 | B1 |
7474223 | Nycz et al. | Jan 2009 | B2 |
7481759 | Whitehurst et al. | Jan 2009 | B2 |
7489970 | Lee et al. | Feb 2009 | B2 |
7496403 | Cao et al. | Feb 2009 | B2 |
7499048 | Sieracki et al. | Mar 2009 | B2 |
7505815 | Lee et al. | Mar 2009 | B2 |
7551960 | Forsberg et al. | Jun 2009 | B2 |
7602384 | Rosenberg et al. | Oct 2009 | B2 |
7617002 | Goetz | Nov 2009 | B2 |
7627372 | Vaisnys et al. | Dec 2009 | B2 |
7640059 | Forsberg et al. | Dec 2009 | B2 |
7657317 | Thacker et al. | Feb 2010 | B2 |
7685005 | Riff et al. | Mar 2010 | B2 |
7711603 | Vanker et al. | May 2010 | B2 |
7720549 | Schroeppel et al. | May 2010 | B2 |
7747330 | Nolan et al. | Jun 2010 | B2 |
7774067 | Keacher et al. | Aug 2010 | B2 |
7778710 | Propato | Aug 2010 | B2 |
7801596 | Fischell et al. | Sep 2010 | B2 |
7801611 | Persen et al. | Sep 2010 | B2 |
7805199 | KenKnight et al. | Sep 2010 | B2 |
7822483 | Stone et al. | Oct 2010 | B2 |
7853323 | Goetz | Dec 2010 | B2 |
7885712 | Goetz et al. | Feb 2011 | B2 |
7890180 | Quiles et al. | Feb 2011 | B2 |
7928995 | Daignault | Apr 2011 | B2 |
7934508 | Behm | May 2011 | B2 |
7940933 | Corndorf | May 2011 | B2 |
7953492 | Corndorf | May 2011 | B2 |
7953612 | Palmese et al. | May 2011 | B1 |
7957808 | Dawant et al. | Jun 2011 | B2 |
7978062 | LaLonde et al. | Jul 2011 | B2 |
7991482 | Bradley | Aug 2011 | B2 |
8014863 | Zhang et al. | Sep 2011 | B2 |
8021298 | Baird et al. | Sep 2011 | B2 |
8027726 | Ternes | Sep 2011 | B2 |
8046241 | Dodson | Oct 2011 | B1 |
8060216 | Greenberg et al. | Nov 2011 | B2 |
8068915 | Lee et al. | Nov 2011 | B2 |
8068918 | Vallapureddy et al. | Nov 2011 | B2 |
8078440 | Otto et al. | Dec 2011 | B2 |
8082162 | Flood | Dec 2011 | B2 |
8121702 | King | Feb 2012 | B2 |
8135566 | Marshall et al. | Mar 2012 | B2 |
8140160 | Pless et al. | Mar 2012 | B2 |
8140167 | Donders et al. | Mar 2012 | B2 |
8160328 | Goetz et al. | Apr 2012 | B2 |
8160704 | Freeberg | Apr 2012 | B2 |
8165385 | Reeves et al. | Apr 2012 | B2 |
8187015 | Boyd et al. | May 2012 | B2 |
8200324 | Shen et al. | Jun 2012 | B2 |
8200340 | Skelton et al. | Jun 2012 | B2 |
8219206 | Skelton et al. | Jul 2012 | B2 |
8233991 | Woods et al. | Jul 2012 | B2 |
8246680 | Betz et al. | Aug 2012 | B2 |
8249713 | Fang et al. | Aug 2012 | B2 |
8255060 | Goetz et al. | Aug 2012 | B2 |
8323218 | Davis et al. | Dec 2012 | B2 |
8326433 | Blum et al. | Dec 2012 | B2 |
8340775 | Cullen et al. | Dec 2012 | B1 |
8382666 | Mao et al. | Feb 2013 | B1 |
8386032 | Bachinski et al. | Feb 2013 | B2 |
8401666 | Skelton et al. | Mar 2013 | B2 |
8428727 | Bolea et al. | Apr 2013 | B2 |
20010037220 | Merry et al. | Nov 2001 | A1 |
20020068956 | Bloemer et al. | Jun 2002 | A1 |
20030076301 | Tsuk et al. | Apr 2003 | A1 |
20030107572 | Smith et al. | Jun 2003 | A1 |
20030139652 | Kang et al. | Jul 2003 | A1 |
20030171911 | Fairweather | Sep 2003 | A1 |
20030177031 | Malek | Sep 2003 | A1 |
20040088374 | Webb et al. | May 2004 | A1 |
20040122477 | Whitehurst et al. | Jun 2004 | A1 |
20040210273 | Wang | Oct 2004 | A1 |
20050107831 | Hill et al. | May 2005 | A1 |
20050149356 | Cyr et al. | Jul 2005 | A1 |
20050168460 | Razdan et al. | Aug 2005 | A1 |
20050277872 | Colby et al. | Dec 2005 | A1 |
20060089888 | Roger | Apr 2006 | A1 |
20060100832 | Bowman | May 2006 | A1 |
20060241720 | Woods et al. | Oct 2006 | A1 |
20060242159 | Bishop et al. | Oct 2006 | A1 |
20060282168 | Sherman et al. | Dec 2006 | A1 |
20070078497 | Vandanacker | Apr 2007 | A1 |
20070093998 | El-Baroudi | Apr 2007 | A1 |
20070179349 | Hoyme et al. | Aug 2007 | A1 |
20070203537 | Goetz et al. | Aug 2007 | A1 |
20070203538 | Stone et al. | Aug 2007 | A1 |
20070203543 | Stone et al. | Aug 2007 | A1 |
20070213790 | Nolan et al. | Sep 2007 | A1 |
20080004675 | King et al. | Jan 2008 | A1 |
20080033303 | Wariar et al. | Feb 2008 | A1 |
20080046036 | King et al. | Feb 2008 | A1 |
20080140161 | Goetz et al. | Jun 2008 | A1 |
20080177362 | Phillips et al. | Jul 2008 | A1 |
20080218517 | Holmdahl | Sep 2008 | A1 |
20080262565 | Bentwich | Oct 2008 | A1 |
20090018617 | Skelton et al. | Jan 2009 | A1 |
20090018619 | Skelton et al. | Jan 2009 | A1 |
20090024178 | Hennig | Jan 2009 | A1 |
20090048871 | Skomra | Feb 2009 | A1 |
20090089034 | Penney et al. | Apr 2009 | A1 |
20090099624 | Kokones et al. | Apr 2009 | A1 |
20090132009 | Torgerson et al. | May 2009 | A1 |
20090136094 | Driver et al. | May 2009 | A1 |
20090196471 | Goetz et al. | Aug 2009 | A1 |
20090234873 | Li et al. | Sep 2009 | A1 |
20090264967 | Giftakis et al. | Oct 2009 | A1 |
20090281596 | King et al. | Nov 2009 | A1 |
20100004033 | Choe et al. | Jan 2010 | A1 |
20100010566 | Thacker et al. | Jan 2010 | A1 |
20100010574 | Skelton et al. | Jan 2010 | A1 |
20100010580 | Skelton et al. | Jan 2010 | A1 |
20100058462 | Chow | Mar 2010 | A1 |
20100076534 | Mock | Mar 2010 | A1 |
20100090004 | Sands et al. | Apr 2010 | A1 |
20100106475 | Smith et al. | Apr 2010 | A1 |
20100123547 | Stevenson et al. | May 2010 | A1 |
20100152534 | Kim et al. | Jun 2010 | A1 |
20100161345 | Cain et al. | Jun 2010 | A1 |
20100198103 | Meadows et al. | Aug 2010 | A1 |
20100198304 | Wang | Aug 2010 | A1 |
20100222845 | Goetz | Sep 2010 | A1 |
20100223020 | Goetz | Sep 2010 | A1 |
20100265072 | Goetz et al. | Oct 2010 | A1 |
20100268304 | Matos | Oct 2010 | A1 |
20100280578 | Skelton et al. | Nov 2010 | A1 |
20110004059 | Arneson et al. | Jan 2011 | A1 |
20110015514 | Skalli et al. | Jan 2011 | A1 |
20110015693 | Williamson | Jan 2011 | A1 |
20110023343 | Turner et al. | Feb 2011 | A1 |
20110038498 | Edgar | Feb 2011 | A1 |
20110040546 | Gerber et al. | Feb 2011 | A1 |
20110040547 | Gerber et al. | Feb 2011 | A1 |
20110046697 | Gerber et al. | Feb 2011 | A1 |
20110054560 | Rosenberg et al. | Mar 2011 | A1 |
20110054870 | Dariush et al. | Mar 2011 | A1 |
20110077459 | Rofougaran | Mar 2011 | A1 |
20110077616 | Bennett et al. | Mar 2011 | A1 |
20110093030 | Goetz et al. | Apr 2011 | A1 |
20110093047 | Davis et al. | Apr 2011 | A1 |
20110093051 | Davis et al. | Apr 2011 | A1 |
20110153341 | Diaz-Cortes | Jun 2011 | A1 |
20110170739 | Gillam et al. | Jul 2011 | A1 |
20110172564 | Drew | Jul 2011 | A1 |
20110172737 | Davis et al. | Jul 2011 | A1 |
20110172744 | Davis et al. | Jul 2011 | A1 |
20110185178 | Gotthardt | Jul 2011 | A1 |
20110191275 | Lujan et al. | Aug 2011 | A1 |
20110224523 | Budiman | Sep 2011 | A1 |
20110246219 | Smith et al. | Oct 2011 | A1 |
20110264165 | Molnar et al. | Oct 2011 | A1 |
20110270358 | Davis et al. | Nov 2011 | A1 |
20110282414 | Kothandaraman et al. | Nov 2011 | A1 |
20110305376 | Neff | Dec 2011 | A1 |
20110307284 | Thompson et al. | Dec 2011 | A1 |
20110313268 | Kokones et al. | Dec 2011 | A1 |
20110313487 | Kokones et al. | Dec 2011 | A1 |
20120041518 | Kim et al. | Feb 2012 | A1 |
20120046715 | Moffitt et al. | Feb 2012 | A1 |
20120071947 | Gupta et al. | Mar 2012 | A1 |
20120083857 | Bradley et al. | Apr 2012 | A1 |
20120084689 | Ledet et al. | Apr 2012 | A1 |
20120089008 | Strehl et al. | Apr 2012 | A1 |
20120109230 | Kothandaraman et al. | May 2012 | A1 |
20120192874 | Bolea et al. | Aug 2012 | A1 |
20120239116 | Lee et al. | Sep 2012 | A1 |
20120256857 | Mak | Oct 2012 | A1 |
20120265269 | Lui et al. | Oct 2012 | A1 |
20120265271 | Goetz | Oct 2012 | A1 |
20120277828 | O'Conner et al. | Nov 2012 | A1 |
20120290034 | Rochat et al. | Nov 2012 | A1 |
20120290041 | Kim et al. | Nov 2012 | A1 |
20120290272 | Bryan | Nov 2012 | A1 |
20120290976 | Lahm et al. | Nov 2012 | A1 |
20120296392 | Lee et al. | Nov 2012 | A1 |
20120296396 | Moffitt et al. | Nov 2012 | A1 |
20120296397 | Vansickle | Nov 2012 | A1 |
20120303087 | Moffitt et al. | Nov 2012 | A1 |
20120310300 | Kaula et al. | Dec 2012 | A1 |
20130013016 | Diebold | Jan 2013 | A1 |
20130023950 | Gauthier | Jan 2013 | A1 |
20130060299 | Polefko et al. | Mar 2013 | A1 |
20130060300 | Polefko et al. | Mar 2013 | A1 |
20130060301 | Polefko et al. | Mar 2013 | A1 |
20130060302 | Polefko et al. | Mar 2013 | A1 |
20130079848 | Campbell et al. | Mar 2013 | A1 |
Number | Date | Country |
---|---|---|
1192972 | Apr 2002 | EP |
2277586 | Jan 2011 | EP |
WO 9959106 | Nov 1999 | WO |
WO 0209808 | Feb 2002 | WO |
WO 02084637 | Oct 2002 | WO |
WO 2009113102 | Sep 2009 | WO |
WO 2011028261 | Mar 2011 | WO |
WO 2011063248 | May 2011 | WO |
WO 2011104028 | Sep 2011 | WO |
WO 2011123669 | Oct 2011 | WO |
WO 2012018851 | Feb 2012 | WO |
WO 2012021862 | Feb 2012 | WO |
WO 2012135949 | Oct 2012 | WO |
WO 2013023085 | Feb 2013 | WO |
Entry |
---|
Synalink Features, SynaMed Web Page, http://synamed.com/synalinkFeatures.html., Copyright 2010, 2 pgs. |
Boston Scientific Corporation, “Boston Scientific Precision Spectra System Programming Manual”, Copyright 2010, 580 pgs. |
Scott Drees et al., Office Action dated Nov. 19, 2013 for U.S. Appl. No. 13/604,285, 23 pages. |
Number | Date | Country | |
---|---|---|---|
20140067011 A1 | Mar 2014 | US |